Financing, Equity Capital Markets
Aptose Biosciences Inc.
12/19
|
$74.2 Million
Âé¶¹´«Ã½ served as sole bookrunner for Aptose Biosciences Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sector
Sub-Sector
Biopharma